Skip to main content
OpenTrials

Clinical trial condition

Astrocytoma, IDH-Mutant, Grade 4

Explore clinical trials studying Astrocytoma, IDH-Mutant, Grade 4. Study availability and eligibility vary by location and protocol.

6 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Astrocytoma, IDH-Mutant, Grade 4 trial results

Recruiting

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

NCT05303519

Conditions
Astrocytoma, Astrocytoma, Grade IV, Astrocytoma, IDH-Mutant, Grade 2, +22 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Mayo Clinic - Arizona Phoenix, Arizona, United States
  • St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • University of California San Diego La Jolla, California, United States
View all 57 locations
View Trial Details
Active, Not Recruiting

A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden

NCT04145115

Conditions
Astrocytoma, Astrocytoma, IDH-Mutant, Grade 4, Diffuse Glioma, +11 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 415 locations
View Trial Details

Related conditions